Your browser doesn't support javascript.
loading
Cushing's disease: role of bilateral adrenalectomy.
Bertherat, Jérôme.
Afiliação
  • Bertherat J; Endocrinology Department, Center for Rare Adrenal Diseases, Cochin Hospital, AP-HP, Université Paris Cité, 75014, Paris, France. Jerome.bertherat@aphp.fr.
Pituitary ; 25(5): 743-745, 2022 Oct.
Article em En | MEDLINE | ID: mdl-35881276
ABSTRACT

INTRODUCTION:

Laparoscopic bilateral adrenalectomy (BAD) is one of the treatments of Cushing's Disease (CD), but its indications and outcome is debated.

METHODS:

The literature on BAD was reviewed as part of a work performed for the Cushing's disease guideline.

RESULTS:

The surgical morbidity of BAD is reported between 10 and 18% and no mortality has been reported in the largest series. Because of the endocrine sacrifice it will be mostly performed after a multidisciplinary team discussion in selected cases of refractory CD (mostly after failure of pituitary surgery and/or medical treatment). It is also frequently discussed in female patients desiring pregnancy. Corticotroph tumor progression occurs in 40% of the patients but is in most patients manageable when detected early by a careful long term monitoring with pituitary MRI and ACTH assays after BAD.

CONCLUSION:

BAD is a safe and effective treatment of CD used in specific situations and requiring long term monitoring.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Guideline / Qualitative_research Limite: Female / Humans / Pregnancy Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Guideline / Qualitative_research Limite: Female / Humans / Pregnancy Idioma: En Ano de publicação: 2022 Tipo de documento: Article